Motsa jiki a kai a kai na rage barazanar kamuwa da nau'ikan cutar kansa daban-daban guda 7

Motsa jiki na yau da kullun yana rage haɗarin kamuwa da cutar kansa iri daban-daban 7 an gano shi a cikin wani bincike da ƙungiyar cutar kansa ta Amurka, Cibiyar Ciwon daji ta ƙasa & Harvard THChan Makarantar Lafiyar Jama'a ta gudanar.

Share Wannan Wallafa

Wani bincike da aka gudanar a Amurka ya gano cewa motsa jiki na yau da kullun yana rage haɗarin kamuwa da cutar kansa iri 7. An gudanar da wannan binciken ne ta hanyar American Cancer Society, Cibiyar Cancer ta Kasa, & Harvard T.Chan Makarantar kiwon lafiyar jama'a. An buga wannan binciken a cikin Journal of Clinical Oncology.

Dalilin binciken

Don ƙayyade ko yawan adadin lokacin motsa jiki na motsa jiki (watau, aikin 7.5-15 mai dacewa daidai [MET] awoyi / sati) ana haɗuwa da ƙananan haɗarin cutar kansa, bayyana fasalin dangantakar amsa-kashi, da bincika ƙungiyoyi tare da matsakaici- da kuma motsa jiki mai tsananin karfi.

Sakamakon binciken

Jimlar mahalarta 755,459 (matsakaiciyar shekaru, shekaru 62 [zangon, 32-91]; 53% mata) an bi su tsawon shekaru 10.1, kuma an sami karuwar cutar kansa 50,620. Haɗuwa cikin adadin aiki (7.5-15 MET hours / week) yana da alaƙa da ƙananan haɗarin ƙimar 7 na nau'ikan nau'ikan cutar kansa guda 15 da aka yi nazari, gami da mallaka (8% -14% ƙananan haɗari a cikin maza), nono (6% -10% ƙananan haɗari), endometrial (10% -18% ƙananan haɗari), koda (11% -17% ƙananan haɗari), myeloma (14% -19% ƙananan haɗari), hanta (18% -27% ƙananan haɗari) , da Non-Hodgkin lymphoma (11% -18% ƙananan haɗari a cikin mata). Amsar maganin ya kasance madaidaiciya a cikin rabin rabin ƙungiyoyi kuma ba layi ba ga wasu. Sakamako don matsakaiciyar ƙarfi da motsa jiki-lokaci na motsa jiki sun haɗu. Daidaitawa don ƙididdigar nauyin jiki ya kawar da haɗuwa tare da ciwon daji na endometrial amma yana da iyakantaccen tasiri akan sauran nau'o'in ciwon daji.
Motsa jiki na yau da kullun yana da alaƙa musamman:

  • 8% ƙananan haɗarin ciwon daji na maza a cikin maza don 7.5 MET hours a mako kuma 14% ƙananan haɗari na 15 MET hours a mako
  • Rashin kasada na 6% na cutar sankarar mama a cikin mata na tsawan awanni 7.5 MET a mako da kuma 10% ƙananan haɗari na sa'o'i 15 MET a mako
  • Riskarin ƙananan 10% na ƙananan ciwon daji na endometrial a cikin mata don awanni 7.5 MET a kowane mako kuma 18% ƙananan haɗari na sa'o'i 15 MET a mako
  • Karancin kaso na 11% na cutar kansa na koda na tsawon sa'o'i 7.5 MET a mako kuma 17% ƙananan haɗari ne na awanni 15 MET a mako
  • Rashin kasada 14% na myeloma mai yawa don awanni 7.5 MET a mako kuma 19% ƙananan haɗari na sa'o'i 15 MET a mako
  • Rashin haɗarin 18% na ciwon hanta na hanta na tsawon sa'o'i 7.5 MET a mako kuma 27% ƙananan haɗari na sa'o'i 15 MET a mako
  • Riskananan 11% ƙananan haɗarin lymphoma na Non-Hodgkin a cikin mata don 7.5 MET hours a mako daya kuma 18% ƙananan haɗari na 15 MET hours a mako

Don haka gaskiya ne cewa motsa jiki na yau da kullun makami ne mai ƙarfi don rigakafin cutar kansa. Abubuwan da aka tabbatar da nau'ikan cutar kansa wanda za'a iya rigakafin sune kansar hanji, kansar mama, Ciwon kanjamau, Ciwon koda, Myeloma da yawa, Ciwan hanta, Myeloma, Non-Hodgkin Lymphoma.
Kawai ta hanyar tafiyar minti 30 a rana yana rage wadannan kasada sosai.

Biyan kuɗi zuwa ga Newsletter

Sami sabuntawa kuma kada ku rasa bulogi daga Cancerfax

Toarin Don Bincika

Fahimtar Ciwon Sakin Cytokine: Dalilai, Alamu, da Jiyya
CAR T-Cell far

Fahimtar Ciwon Sakin Cytokine: Dalilai, Alamu, da Jiyya

Ciwon Saki na Cytokine (CRS) wani tsarin rigakafi ne wanda sau da yawa ke haifar da wasu jiyya kamar immunotherapy ko CAR-T cell far. Ya ƙunshi yawan sakin cytokines, yana haifar da alamun bayyanar da ke fitowa daga zazzabi da gajiya zuwa rikice-rikice masu haɗari masu haɗari kamar lalacewar gabbai. Gudanarwa yana buƙatar kulawa da hankali da dabarun shiga tsakani.

Matsayin ma'aikatan lafiya a cikin nasarar CAR T Cell therapy
CAR T-Cell far

Matsayin ma'aikatan lafiya a cikin nasarar CAR T Cell therapy

Ma'aikatan jinya suna taka muhimmiyar rawa a cikin nasarar CAR T-cell far ta hanyar tabbatar da kulawar marasa lafiya a duk lokacin aikin jiyya. Suna ba da tallafi mai mahimmanci yayin sufuri, lura da mahimman alamun marasa lafiya, da gudanar da ayyukan gaggawa na likita idan rikitarwa ta taso. Amsar su da sauri da kulawar ƙwararrun suna ba da gudummawa ga amincin gabaɗaya da ingancin jiyya, sauƙaƙe sauye-sauye masu sauƙi tsakanin saitunan kiwon lafiya da haɓaka sakamakon haƙuri a cikin ƙalubalen shimfidar wurare na ci-gaba na salon salula.

Ana buƙatar taimako? Ourungiyarmu a shirye take don taimaka muku.

Muna fatan samun lafiya cikin sauri na masoyinku da na kusa.

Fara hira
Muna Kan layi! Yi Taɗi da Mu!
Duba lambar
Hello,

Barka da zuwa CancerFax!

CancerFax wani dandali ne na majagaba wanda aka keɓe don haɗa mutane da ke fuskantar ciwon daji na zamani tare da hanyoyin kwantar da hankali kamar CAR T-Cell far, TIL far, da gwaji na asibiti a duk duniya.

Bari mu san abin da za mu iya yi muku.

1) Maganin ciwon daji a kasashen waje?
2) CAR T-Cell far
3) rigakafin cutar daji
4) Shawarar bidiyo ta kan layi
5) Maganin Proton